Leonidas Apostolidis

Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial

Georg Martin Haag, Christoph Springfeld, Barbara Grün et al. · European Journal of Cancer · 2022 · 95 citations

Medicine, Oncology, Chemotherapy +11

Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity

Clemens Kratochwil, Leonidas Apostolidis, Hendrik Rathke et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 85 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

The patient-level effect of the cost of Cancer care – financial burden in German Cancer patients

Katja Mehlis, Julian Witte, Bastian Surmann et al. · BMC Cancer · 2020 · 68 citations · Full text

Medicine, Oncology, Health Economics +16

Prognostic significance of microsatellite‐instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy

Georg Martin Haag, Elena Czink, Aysel Ahadova et al. · International Journal of Cancer · 2018 · 58 citations · Full text

Medicine, Oncology, Surgery +17

A phase II, open label, multicenter trial of avelumab in patients with advanced, metastatic high-grade neuroendocrine carcinomas NEC G3 (WHO 2010) progressive after first-line chemotherapy (AVENEC).

Christian Fottner, Leonidas Apostolidis, Martina Ferrata et al. · Journal of Clinical Oncology · 2019 · 51 citations

Medicine, Oncology, Pharmacology +16